Free Trial

Lam Research (LRCX) Financials

Lam Research logo
$238.77 +16.38 (+7.37%)
As of 02:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Lam Research

Annual Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Net Income / (Loss) Attributable to Common Shareholders
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Consolidated Net Income / (Loss)
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Net Income / (Loss) Continuing Operations
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Total Pre-Tax Income
960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958 8,262
Total Operating Income
1,074 1,902 3,213 2,465 2,674 4,482 5,382 5,175 4,264 5,901 8,200
Total Gross Profit
2,619 3,603 5,165 4,358 4,609 6,805 7,872 7,777 7,053 8,979 11,725
Total Revenue
5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436 23,233
Operating Revenue
5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436 23,233
Total Cost of Revenue
3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,853 9,457 11,507
Operating Cost of Revenue
3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,853 9,457 11,507
Total Operating Expenses
1,545 1,701 1,952 1,894 1,935 2,323 2,490 2,602 2,789 3,078 3,526
Selling, General & Admin Expense
631 667 762 702 682 830 886 833 868 982 1,150
Research & Development Expense
914 1,034 1,190 1,191 1,252 1,493 1,604 1,727 1,902 2,096 2,376
Restructuring Charge
- - - - - - - 42 18 0.00 0.00
Total Other Income / (Expense), net
-114 -90 -62 -18 -99 -111 -189 -66 96 57 63
Other Income / (Expense), net
-114 -90 -62 -18 -99 -111 -189 -66 96 57 63
Income Tax Expense
46 114 771 255 323 462 588 598 532 600 997
Basic Earnings per Share
$5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $3.33 $2.91 $4.17 $5.79
Weighted Average Basic Shares Outstanding
158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 1.35B 1.31B 1.29B 1.26B
Diluted Earnings per Share
$5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $3.32 $2.90 $4.15 $5.76
Weighted Average Diluted Shares Outstanding
175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 1.36B 1.32B 1.29B 1.26B
Weighted Average Basic & Diluted Shares Outstanding
159M 162.20M 161.60M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B 1.25B

Quarterly Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
Net Income / (Loss) Attributable to Common Shareholders
966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277 2,753
Consolidated Net Income / (Loss)
966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277 2,753
Net Income / (Loss) Continuing Operations
966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277 2,753
Total Pre-Tax Income
1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012 2,555 3,312
Total Operating Income
1,057 1,127 1,264 1,334 1,562 1,741 1,829 1,810 2,047 2,513 3,284
Total Gross Profit
1,801 1,840 2,003 2,073 2,314 2,590 2,685 2,651 2,911 3,479 4,299
Total Revenue
3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841 6,722 8,219
Operating Revenue
3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841 6,722 8,219
Total Cost of Revenue
1,993 2,031 2,165 2,303 2,406 2,582 2,639 2,694 2,931 3,243 3,921
Operating Cost of Revenue
1,993 2,011 2,165 2,303 2,406 2,582 2,639 2,694 2,931 3,243 3,921
Total Operating Expenses
743 714 738 739 752 849 856 841 864 965 1,015
Selling, General & Admin Expense
216 216 243 244 226 268 279 268 280 322 349
Research & Development Expense
512 498 495 495 526 580 576 573 583 643 666
Total Other Income / (Expense), net
36 28 30 14 -25 38 30 26 -35 42 28
Other Income / (Expense), net
36 28 30 14 -25 38 30 26 -35 42 28
Income Tax Expense
127 134 178 157 206 59 291 243 186 278 559
Basic Earnings per Share
$0.74 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46 $1.81 $2.20
Weighted Average Basic Shares Outstanding
1.31B 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B 1.26B 1.25B
Diluted Earnings per Share
$0.73 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45 $1.81 $2.19
Weighted Average Diluted Shares Outstanding
1.32B 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B 1.26B 1.26B
Weighted Average Basic & Diluted Shares Outstanding
130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B 1.25B 1.25B

Annual Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Net Change in Cash & Equivalents
3,811 -2,656 2,135 -855 1,256 -498 -897 1,814 263 557 -810
Net Cash From Operating Activities
1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173 5,858
Net Cash From Continuing Operating Activities
1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173 5,858
Net Income / (Loss) Continuing Operations
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Consolidated Net Income / (Loss)
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Depreciation Expense
291 307 326 309 269 307 334 342 360 386 442
Non-Cash Adjustments To Reconcile Net Income
191 166 248 189 196 203 214 339 303 350 354
Changes in Operating Assets and Liabilities, net
-101 -167 -314 487 -590 -830 -2,054 -13 161 79 -2,203
Net Cash From Investing Activities
469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708 -922
Net Cash From Continuing Investing Activities
469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708 -922
Purchase of Property, Plant & Equipment
-175 -157 -273 -303 -203 -349 -546 -502 -397 -759 -966
Sale and/or Maturity of Investments
643 2,698 5,686 1,604 2,883 3,854 1,734 98 38 0.00 0.00
Other Investing Activities, net
1.64 -13 -15 -7.36 -26 -42 -7.58 -11 -12 51 44
Net Cash From Financing Activities
2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937 -5,718
Net Cash From Continuing Financing Activities
2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937 -5,718
Repayment of Debt
-0.49 -1,688 -1,506 -493 -1,916 -864 -12 -27 -270 -507 -769
Repurchase of Common Equity
-158 -812 -2,653 -3,781 -1,370 -2,698 -3,866 -2,017 -2,843 -3,422 -3,851
Payment of Dividends
-190 -243 -308 -678 -657 -727 -815 -908 -1,019 -1,150 -1,271
Issuance of Common Equity
59 73 85 85 94 122 114 121 136 143 173
Effect of Exchange Rate Changes
-0.72 -0.06 2.59 -4.04 -2.75 7.22 -30 0.13 -22 28 -27
Cash Interest Paid
- 105 84 77 172 204 176 175 173 172 150

Quarterly Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
Net Change in Cash & Equivalents
48 177 221 -395 -214 945 304 -516 -1,429 831 1,853
Net Cash From Operating Activities
1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141 1,457 3,498
Net Cash From Continuing Operating Activities
1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141 1,457 3,498
Net Income / (Loss) Continuing Operations
966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277 2,753
Consolidated Net Income / (Loss)
966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277 2,753
Depreciation Expense
90 88 94 96 97 98 102 104 116 120 122
Non-Cash Adjustments To Reconcile Net Income
87 75 80 73 89 109 95 69 94 96 142
Changes in Operating Assets and Liabilities, net
242 -321 278 -619 -208 627 13 -286 -894 -1,036 480
Net Cash From Investing Activities
-92 -102 -111 -175 -293 -129 -186 -258 -335 -144 -267
Net Cash From Continuing Investing Activities
-92 -102 -111 -175 -293 -129 -186 -258 -335 -144 -267
Purchase of Property, Plant & Equipment
-104 -101 -111 -188 -288 -172 -185 -261 -332 -189 -258
Other Investing Activities, net
-3.36 -0.87 0.04 13 -4.86 43 -0.93 3.10 -2.98 45 -9.29
Net Cash From Financing Activities
-1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231 -480 -1,382
Net Cash From Continuing Financing Activities
-1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231 -480 -1,382
Repayment of Debt
-0.76 -8.82 -1.26 -0.27 -504 -2.31 -14 -2.58 -751 -1.64 -36
Repurchase of Common Equity
-981 -374 -997 -698 -435 -1,292 -976 -1,466 -1,163 -247 -1,025
Payment of Dividends
-263 -261 -261 -298 -296 -295 -292 -328 -326 -325 -325
Issuance of Common Equity
8.24 70 -0.04 60 1.99 80 0.00 71 9.17 93 4.26
Effect of Exchange Rate Changes
-8.45 -9.62 23 -26 2.38 29 -7.06 -13 -4.98 -2.06 4.66

Annual Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Total Assets
12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345 23,530
Total Current Assets
9,213 9,142 9,150 8,560 10,854 11,652 12,285 13,228 12,883 14,517 15,611
Cash & Equivalents
5,039 2,378 4,512 3,658 4,915 4,418 3,522 5,337 5,848 6,391 5,579
Accounts Receivable
1,262 1,673 2,177 1,456 2,097 3,026 4,314 2,823 2,519 3,378 5,340
Inventories, net
972 1,233 1,876 1,540 1,900 2,689 3,966 4,816 4,218 4,308 4,276
Prepaid Expenses
151 195 147 134 146 208 347 252 298 440 416
Plant, Property, & Equipment, net
640 686 903 0.00 0.00 0.00 1,648 1,857 2,155 2,429 2,956
Total Noncurrent Assets
2,412 2,295 2,427 3,441 3,706 4,240 3,263 3,697 3,707 4,400 4,963
Goodwill
1,386 1,386 1,485 1,485 1,484 1,490 1,515 1,622 1,765 1,809 1,896
Other Noncurrent Operating Assets
210 242 368 1,484 1,799 2,365 1,394 1,906 1,942 2,591 3,067
Total Liabilities & Shareholders' Equity
12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345 23,530
Total Liabilities
6,162 5,135 5,899 7,278 9,376 9,865 10,917 10,571 10,205 11,484 11,059
Total Current Liabilities
2,418 2,950 3,150 2,372 3,162 3,528 4,565 4,185 4,338 6,568 5,937
Short-Term Debt
948 908 610 667 840 11 7.38 8.36 505 754 4.07
Accounts Payable
348 465 511 377 592 830 1,011 471 614 854 1,302
Accrued Expenses
773 969 1,309 947 1,273 1,719 1,974 2,011 1,802 2,394 2,352
Current Deferred Revenue
349 608 720 381 458 967 - 1,695 1,418 2,566 2,279
Total Noncurrent Liabilities
3,744 2,185 2,749 4,906 6,213 6,337 6,353 6,387 5,867 4,915 5,122
Long-Term Debt
3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730 3,730
Noncurrent Deferred Revenue
232 120 852 893 910 948 931 882 813 603 681
Other Noncurrent Operating Liabilities
135 280 91 191 333 399 423 501 575 582 710
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Total Preferred & Common Equity
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Common Stock
5,573 5,846 6,145 6,410 6,696 7,053 7,415 7,809 8,224 8,699 9,246
Retained Earnings
4,820 6,250 8,261 9,931 11,521 14,685 18,455 22,032 24,811 28,989 34,950
Treasury Stock
-4,429 -5,216 -7,846 -11,603 -12,950 -15,647 -19,481 -21,530 -24,366 -27,763 -31,598
Accumulated Other Comprehensive Income / (Loss)
-69 -62 -57 -64 -94 -64 -110 -101 -130 -62 -127

Quarterly Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 9/28/2025 12/28/2025 3/29/2026 9/27/2026
Total Assets
18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792 26,353
Total Current Assets
12,994 13,055 12,488 12,883 13,492 13,613 13,460 14,807 14,018 13,297 18,124
Cash & Equivalents
5,126 5,623 5,672 5,848 6,067 5,665 5,451 6,693 6,180 4,751 7,437
Accounts Receivable
2,811 2,707 2,204 2,519 2,937 3,305 3,228 3,633 3,492 4,133 5,658
Inventories, net
4,748 4,430 4,323 4,218 4,210 4,358 4,463 4,095 4,038 4,000 4,551
Prepaid Expenses
278 279 290 298 278 284 318 386 308 413 478
Plant, Property, & Equipment, net
2,111 2,147 2,182 2,155 2,214 2,314 2,372 2,511 2,711 2,854 3,126
Total Noncurrent Assets
3,434 3,582 3,609 3,707 3,826 3,913 4,136 4,583 4,662 4,641 5,103
Goodwill
1,626 1,627 1,627 1,765 1,758 1,761 1,795 1,827 1,864 1,882 1,912
Other Noncurrent Operating Assets
1,650 1,804 1,840 1,942 2,068 2,152 2,341 2,756 2,798 2,759 3,191
Total Liabilities & Shareholders' Equity
18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792 26,353
Total Liabilities
10,491 10,561 10,258 10,205 11,061 11,032 10,457 11,707 11,246 10,207 12,445
Total Current Liabilities
4,247 4,272 4,430 4,338 5,343 5,350 5,490 6,708 6,213 5,242 7,312
Short-Term Debt
3.86 3.78 505 505 505 504 754 754 754 4.10 3.49
Accounts Payable
528 500 532 614 704 822 853 863 1,027 1,072 1,592
Accrued Expenses
2,120 1,976 1,792 1,802 2,196 2,096 2,000 2,444 2,267 2,075 3,287
Current Deferred Revenue
1,595 - 1,602 1,418 1,937 - 1,882 2,646 2,165 2,091 2,429
Total Noncurrent Liabilities
6,244 6,289 5,827 5,867 5,718 5,682 4,967 5,000 5,033 4,965 5,132
Long-Term Debt
4,980 4,980 4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730 3,732
Noncurrent Deferred Revenue
781 798 832 813 665 670 691 646 668 622 684
Other Noncurrent Operating Liabilities
483 511 517 575 574 534 547 624 635 613 716
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585 13,908
Total Preferred & Common Equity
8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585 13,908
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585 13,908
Common Stock
7,879 7,997 8,082 8,224 8,304 8,441 8,530 8,796 8,950 9,055 9,365
Retained Earnings
22,655 23,347 24,052 24,811 25,630 26,525 27,561 30,230 31,498 32,998 37,291
Treasury Stock
-22,366 -23,004 -23,985 -24,366 -25,375 -26,024 -26,456 -28,760 -30,204 -31,348 -32,620
Accumulated Other Comprehensive Income / (Loss)
-121 -118 -128 -130 -88 -134 -124 -74 -99 -121 -127

Annual Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
DEI Shares Outstanding
- - - - - - - - - - 1,250,571,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,250,571,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 5.81
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.91% 36.15% 38.23% -12.85% 4.05% 45.61% 17.78% 1.17% -14.48% 23.68% 26.02%
EBITDA Growth
22.81% 71.35% 62.91% -21.09% 3.18% 64.51% 18.15% -1.36% -13.42% 34.42% 37.19%
EBIT Growth
29.60% 88.69% 73.97% -22.38% 5.25% 69.74% 18.81% -1.62% -14.66% 36.65% 38.68%
NOPAT Growth
46.66% 74.29% 36.16% -9.04% 5.91% 71.41% 19.08% -4.27% -18.07% 41.77% 35.87%
Net Income Growth
39.43% 85.74% 40.22% -7.95% 2.75% 73.57% 17.83% -2.05% -15.14% 39.98% 35.59%
EPS Growth
41.08% 77.01% 42.53% 4.02% 10.22% 78.15% 21.75% 1.40% -12.68% 43.10% 38.80%
Operating Cash Flow Growth
94.38% 56.70% 30.87% 19.59% -33.05% 68.74% -13.61% 67.08% -10.17% 32.69% -5.11%
Free Cash Flow Firm Growth
96.74% 54.53% 15.50% 22.37% -25.76% 62.99% -18.25% 66.02% -2.62% 27.15% -9.69%
Invested Capital Growth
-3.15% 1.01% 12.04% -6.96% 14.27% 25.24% 46.12% 6.91% -2.66% 3.66% 33.57%
Revenue Q/Q Growth
1.11% 11.07% 7.59% -7.34% 4.48% 10.20% 2.93% -7.57% 4.66% 7.59% 7.15%
EBITDA Q/Q Growth
10.23% 19.57% 11.34% -11.96% 5.35% 13.82% 1.09% -8.30% 6.53% 11.12% 10.08%
EBIT Q/Q Growth
13.11% 21.57% 12.68% -12.48% 5.70% 14.71% 0.98% -8.84% 7.14% 11.71% 10.37%
NOPAT Q/Q Growth
15.46% 15.83% 25.60% -17.56% 7.15% 12.52% 3.58% -10.21% 5.70% 14.93% 8.34%
Net Income Q/Q Growth
16.23% 18.70% 26.23% -17.95% 7.38% 12.95% 1.42% -8.26% 6.03% 15.02% 8.31%
EPS Q/Q Growth
16.00% 17.86% 27.37% -13.84% 8.71% 13.69% 2.50% -7.52% 6.38% 14.33% 7.26%
Operating Cash Flow Q/Q Growth
57.34% 30.34% -1.75% 5.38% -3.07% 21.01% -24.24% 15.08% -5.30% 37.75% -15.77%
Free Cash Flow Firm Q/Q Growth
24.23% 11.70% -1.43% 7.44% -4.37% 24.56% -26.52% 8.97% -1.19% 47.58% -19.40%
Invested Capital Q/Q Growth
-4.05% -2.33% 13.24% -5.32% 1.05% -1.98% 14.71% 1.18% 4.66% -6.90% 11.06%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.49% 44.97% 46.63% 45.15% 45.88% 46.53% 45.69% 44.62% 47.32% 48.71% 50.47%
EBITDA Margin
21.26% 26.75% 31.53% 28.55% 28.31% 31.98% 32.08% 31.28% 31.67% 34.41% 37.46%
Operating Margin
18.25% 23.74% 29.01% 25.53% 26.62% 30.64% 31.24% 29.69% 28.61% 32.01% 35.29%
EBIT Margin
16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32% 35.56%
Profit (Net Income) Margin
15.53% 21.19% 21.49% 22.70% 22.42% 26.72% 26.73% 25.88% 25.68% 29.06% 31.27%
Tax Burden Percent
95.20% 93.71% 75.53% 89.57% 87.45% 89.42% 88.68% 88.29% 87.79% 89.93% 87.93%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
4.80% 6.29% 24.47% 10.43% 12.55% 10.58% 11.32% 11.71% 12.21% 10.07% 12.07%
Return on Invested Capital (ROIC)
30.04% 52.95% 67.66% 60.34% 61.88% 88.31% 76.84% 59.88% 48.11% 67.90% 77.61%
ROIC Less NNEP Spread (ROIC-NNEP)
34.73% 55.62% 69.12% 61.16% 69.24% 97.63% -210.15% 44.85% 33.91% 64.19% 74.67%
Return on Net Nonoperating Assets (RNNOA)
-14.07% -27.01% -32.57% -21.56% -16.42% -18.58% -1.99% 2.39% -2.41% -9.67% -12.54%
Return on Equity (ROE)
15.97% 25.94% 35.09% 38.77% 45.46% 69.73% 74.85% 62.27% 45.71% 58.24% 65.07%
Cash Return on Invested Capital (CROIC)
33.24% 51.95% 56.31% 67.55% 48.56% 65.89% 39.36% 53.20% 50.81% 64.31% 48.86%
Operating Return on Assets (OROA)
8.88% 14.86% 25.62% 19.99% 19.39% 28.71% 31.39% 28.40% 23.24% 29.72% 36.82%
Return on Assets (ROA)
8.45% 13.92% 19.35% 17.90% 16.96% 25.67% 27.84% 25.08% 20.40% 26.73% 32.38%
Return on Common Equity (ROCE)
15.34% 25.19% 34.45% 38.34% 45.18% 69.66% 74.85% 62.27% 45.71% 58.24% 65.07%
Return on Equity Simple (ROE_SIMPLE)
15.51% 24.90% 36.62% 46.89% 43.53% 64.85% 73.35% 54.94% 44.82% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,569 3,743 5,307 7,210
NOPAT Margin
17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.22% 25.11% 28.79% 31.04%
Net Nonoperating Expense Percent (NNEP)
-4.68% -2.67% -1.45% -0.82% -7.36% -9.32% 286.99% 15.03% 14.21% 3.71% 2.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 36.99% 44.49%
Cost of Revenue to Revenue
55.51% 55.03% 53.37% 54.85% 54.12% 53.47% 54.31% 55.38% 52.68% 51.30% 49.53%
SG&A Expenses to Revenue
10.72% 8.33% 6.88% 7.28% 6.79% 5.67% 5.14% 4.78% 5.83% 5.33% 4.95%
R&D to Revenue
15.52% 12.90% 10.74% 12.34% 12.47% 10.21% 9.31% 9.91% 12.76% 11.37% 10.23%
Operating Expenses to Revenue
26.24% 21.23% 17.62% 19.62% 19.26% 15.88% 14.45% 14.93% 18.71% 16.70% 15.17%
Earnings before Interest and Taxes (EBIT)
960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958 8,262
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,251 2,144 3,493 2,756 2,844 4,678 5,527 5,452 4,720 6,344 8,704
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.98 3.24 4.03 5.65 8.11 14.41 9.71 9.86 16.30 12.61 38.01
Price to Tangible Book Value (P/TBV)
2.96 4.39 5.57 8.88 11.92 19.71 13.08 12.62 20.55 15.44 44.83
Price to Revenue (P/Rev)
1.98 2.75 2.36 2.73 4.18 5.94 3.54 4.65 9.34 6.74 20.41
Price to Earnings (P/E)
12.76 13.00 10.99 12.04 18.63 22.22 13.24 17.95 36.37 23.20 65.25
Dividend Yield
1.64% 1.21% 1.60% 2.50% 1.59% 0.85% 1.36% 1.14% 0.75% 0.95% 0.27%
Earnings Yield
7.83% 7.69% 9.10% 8.30% 5.37% 4.50% 7.55% 5.57% 2.75% 4.31% 1.53%
Enterprise Value to Invested Capital (EV/IC)
2.72 5.51 6.19 7.16 10.13 17.01 8.42 10.23 18.03 15.39 44.44
Enterprise Value to Revenue (EV/Rev)
1.55 2.32 2.12 2.61 4.06 5.87 3.60 4.63 9.28 6.64 20.33
Enterprise Value to EBITDA (EV/EBITDA)
7.29 8.69 6.72 9.16 14.35 18.35 11.23 14.80 29.31 19.30 54.25
Enterprise Value to EBIT (EV/EBIT)
9.50 10.28 7.44 10.32 15.85 19.64 11.95 15.79 31.73 20.55 57.15
Enterprise Value to NOPAT (EV/NOPAT)
8.92 10.45 9.67 11.43 17.45 21.42 13.01 17.65 36.96 23.07 65.49
Enterprise Value to Operating Cash Flow (EV/OCF)
7.04 9.18 8.83 7.95 19.19 23.93 20.03 15.57 29.74 19.83 80.62
Enterprise Value to Free Cash Flow (EV/FCFF)
8.06 10.65 11.62 10.21 22.24 28.70 25.39 19.87 35.00 24.36 104.03
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.71 0.39 0.37 0.95 1.12 0.83 0.80 0.61 0.58 0.45 0.30
Long-Term Debt to Equity
0.55 0.26 0.27 0.81 0.96 0.83 0.80 0.61 0.52 0.38 0.30
Financial Leverage
-0.41 -0.49 -0.47 -0.35 -0.24 -0.19 0.01 0.05 -0.07 -0.15 -0.17
Leverage Ratio
1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18 2.01
Compound Leverage Factor
1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18 2.01
Debt to Total Capital
41.48% 27.82% 26.86% 48.73% 52.85% 45.35% 44.36% 37.90% 36.85% 31.26% 23.05%
Short-Term Debt to Total Capital
9.09% 9.38% 6.78% 7.24% 7.64% 0.10% 0.07% 0.06% 3.73% 5.26% 0.03%
Long-Term Debt to Total Capital
32.40% 18.44% 20.08% 41.49% 45.21% 45.25% 44.30% 37.84% 33.12% 26.00% 23.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.99% 1.75% 0.87% 0.54% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
56.53% 70.42% 72.27% 50.73% 47.05% 54.65% 55.64% 62.10% 63.15% 68.74% 76.95%
Debt to EBITDA
3.46 1.26 0.69 1.63 2.04 1.07 0.91 0.92 1.06 0.71 0.43
Net Debt to EBITDA
-2.20 -1.68 -0.80 -0.43 -0.41 -0.21 0.20 -0.06 -0.18 -0.30 -0.21
Long-Term Debt to EBITDA
2.70 0.83 0.52 1.39 1.75 1.07 0.90 0.92 0.95 0.59 0.43
Debt to NOPAT
4.23 1.51 1.00 2.03 2.49 1.25 1.05 1.10 1.33 0.85 0.52
Net Debt to NOPAT
-2.69 -2.02 -1.15 -0.54 -0.49 -0.24 0.23 -0.07 -0.23 -0.36 -0.26
Long-Term Debt to NOPAT
3.30 1.00 0.74 1.73 2.13 1.25 1.05 1.10 1.20 0.70 0.52
Altman Z-Score
3.09 5.07 5.89 5.43 5.70 9.02 7.39 8.64 12.15 10.63 30.44
Noncontrolling Interest Sharing Ratio
3.93% 2.88% 1.83% 1.13% 0.61% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.81 3.10 2.90 3.61 3.43 3.30 2.69 3.16 2.97 2.21 2.63
Quick Ratio
3.35 2.62 2.26 2.90 2.79 2.48 1.75 1.95 1.93 1.49 1.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,132 1,749 2,020 2,472 1,835 2,991 2,445 4,059 3,953 5,026 4,539
Operating Cash Flow to CapEx
738.60% 1,299.76% 971.13% 1,046.49% 1,046.28% 1,027.84% 567.67% 1,032.55% 1,172.83% 813.14% 606.13%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.66 0.90 0.79 0.76 0.96 1.04 0.97 0.79 0.92 1.04
Accounts Receivable Turnover
5.00 5.46 5.75 5.32 5.65 5.71 4.69 4.88 5.58 6.25 5.33
Inventory Turnover
3.41 4.00 3.80 3.10 3.16 3.41 2.81 2.20 1.74 2.22 2.68
Fixed Asset Turnover
9.34 12.09 13.95 0.00 0.00 0.00 0.00 9.95 7.43 8.04 8.63
Accounts Payable Turnover
10.08 10.85 12.12 11.93 11.22 11.00 10.16 13.03 14.48 12.88 10.67
Days Sales Outstanding (DSO)
73.04 66.85 63.44 68.67 64.55 63.93 77.76 74.74 65.41 58.38 68.48
Days Inventory Outstanding (DIO)
106.99 91.24 95.98 117.75 115.49 107.09 129.84 166.07 209.96 164.54 136.14
Days Payable Outstanding (DPO)
36.22 33.64 30.12 30.59 32.53 33.18 35.91 28.02 25.21 28.33 34.20
Cash Conversion Cycle (CCC)
143.81 124.45 129.30 155.83 147.51 137.84 171.68 212.78 250.17 194.59 170.42
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,350 3,383 3,791 3,527 4,030 5,047 7,375 7,885 7,675 7,955 10,626
Invested Capital Turnover
1.73 2.38 3.09 2.64 2.66 3.22 2.77 2.28 1.92 2.36 2.50
Increase / (Decrease) in Invested Capital
-109 34 407 -264 503 1,017 2,328 510 -210 281 2,671
Enterprise Value (EV)
9,122 18,631 23,463 25,242 40,807 85,847 62,081 80,661 138,355 122,424 472,234
Market Capitalization
11,667 22,065 26,174 26,389 41,949 86,827 60,984 80,987 139,220 124,330 474,079
Book Value per Share
$36.93 $42.26 $39.63 $31.17 $35.63 $42.26 $45.26 $61.11 $65.32 $7.71 $9.97
Tangible Book Value per Share
$24.71 $31.12 $28.65 $19.83 $24.25 $30.88 $33.60 $47.78 $51.82 $6.30 $8.46
Total Capital
10,428 9,681 8,997 9,213 10,994 11,029 11,284 13,222 13,523 14,346 16,205
Total Debt
4,326 2,693 2,417 4,490 5,811 5,002 5,006 5,012 4,983 4,485 3,735
Total Long-Term Debt
3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730 3,730
Net Debt
-2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906 -1,845
Capital Expenditures (CapEx)
175 156 273 303 203 349 546 502 397 759 966
Debt-free, Cash-free Net Working Capital (DFCFNWC)
915 1,060 1,660 1,425 1,821 2,407 4,070 3,715 3,202 2,312 4,098
Debt-free Net Working Capital (DFNWC)
7,743 7,101 6,610 6,856 8,531 8,136 7,728 9,052 9,050 8,703 9,678
Net Working Capital (NWC)
6,795 6,192 6,000 6,189 7,691 8,125 7,720 9,043 8,545 7,949 9,673
Net Nonoperating Expense (NNE)
109 85 46 16 86 99 167 58 -85 -51 -55
Net Nonoperating Obligations (NNO)
-2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906 -1,845
Total Depreciation and Amortization (D&A)
291 332 341 309 269 307 334 342 360 386 442
Debt-free, Cash-free Net Working Capital to Revenue
15.54% 13.22% 14.99% 14.76% 18.13% 16.46% 23.63% 21.31% 21.48% 12.54% 17.64%
Debt-free Net Working Capital to Revenue
131.55% 88.61% 59.67% 71.02% 84.93% 55.63% 44.86% 51.94% 60.71% 47.21% 41.65%
Net Working Capital to Revenue
115.45% 77.27% 54.16% 64.11% 76.57% 55.55% 44.82% 51.89% 57.33% 43.12% 41.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $33.30 $29.13 $4.17 $5.79
Adjusted Weighted Average Basic Shares Outstanding
158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 135.47M 131.41M 1.29B 1.26B
Adjusted Diluted Earnings per Share
$5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $33.21 $29.00 $4.15 $5.76
Adjusted Weighted Average Diluted Shares Outstanding
175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 135.83M 132.00M 1.29B 1.26B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
160.26M 162.45M 157.58M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B 1.25B
Normalized Net Operating Profit after Tax (NOPAT)
1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,606 3,743 5,307 7,210
Normalized NOPAT Margin
17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.43% 25.11% 28.79% 31.04%
Pre Tax Income Margin
16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32% 35.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.83% 14.34% 12.92% 30.95% 29.17% 18.60% 17.70% 20.13% 26.62% 21.45% 17.49%
Augmented Payout Ratio
38.16% 62.15% 124.37% 203.47% 90.00% 87.62% 101.64% 64.84% 100.89% 85.32% 70.50%

Quarterly Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
DEI Shares Outstanding
- - - - - - - - 1,248,771,000.00 1,250,571,000.00 1,251,321,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - 1,248,771,000.00 1,250,571,000.00 1,251,321,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.46 1.82 2.20
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.96% 20.71% 19.70% 16.44% 24.43% 33.58% 27.74% 22.14% 23.76% 29.99% 54.38%
EBITDA Growth
14.80% 30.37% 24.41% 22.61% 38.12% 51.07% 41.21% 34.35% 30.22% 42.47% 75.15%
EBIT Growth
16.43% 33.67% 26.19% 24.02% 40.57% 54.11% 43.64% 36.23% 30.90% 43.63% 78.16%
NOPAT Growth
14.33% 25.38% 23.20% 26.97% 44.80% 69.07% 41.52% 33.32% 37.36% 33.07% 76.86%
Net Income Growth
18.65% 27.13% 25.81% 24.81% 37.78% 68.59% 40.51% 33.83% 37.18% 32.39% 75.51%
EPS Growth
22.13% 28.81% 25.81% 27.78% 41.10% 71.79% 44.19% 36.96% 40.78% 35.07% 76.61%
Operating Cash Flow Growth
-19.79% -23.18% 64.90% -48.97% -5.50% 196.16% 13.42% 99.48% -12.78% -42.95% 96.61%
Free Cash Flow Firm Growth
354.85% 323.80% 97.59% -66.00% -89.88% 16.39% -39.91% 100.61% 491.78% -130.70% -46.55%
Invested Capital Growth
-5.89% -2.66% -6.18% 7.36% 16.52% 3.66% 8.06% 3.99% 11.98% 33.57% 27.84%
Revenue Q/Q Growth
0.94% 2.05% 7.66% 4.99% 7.86% 9.56% 2.95% 0.39% 9.29% 15.08% 22.27%
EBITDA Q/Q Growth
0.43% 5.04% 11.74% 4.02% 13.14% 14.89% 4.44% -1.03% 9.65% 25.70% 28.40%
EBIT Q/Q Growth
0.56% 5.60% 12.12% 4.16% 13.99% 15.76% 4.51% -1.21% 9.53% 27.02% 29.63%
NOPAT Q/Q Growth
0.63% 6.61% 9.52% 8.06% 14.76% 24.49% -8.33% 1.80% 18.24% 20.59% 21.84%
Net Income Q/Q Growth
1.21% 5.64% 9.43% 6.68% 11.73% 29.27% -8.80% 1.62% 14.52% 24.75% 20.90%
EPS Q/Q Growth
1.66% 5.99% 9.43% 6.98% 11.96% 30.10% -7.46% 1.61% 15.08% 24.83% 20.99%
Operating Cash Flow Q/Q Growth
-4.75% -37.72% 81.87% -52.70% 76.38% 95.18% -30.35% -16.80% -22.88% 27.67% 140.02%
Free Cash Flow Firm Q/Q Growth
-23.81% -13.48% 30.84% -60.58% -77.33% 895.44% -32.44% 31.59% -33.13% -151.64% 217.62%
Invested Capital Q/Q Growth
-3.10% 4.66% -3.74% 9.97% 5.17% -6.90% 0.35% 5.83% 13.25% 11.06% -3.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.46% 47.53% 48.05% 47.37% 49.02% 50.08% 50.43% 49.60% 49.83% 51.75% 52.30%
EBITDA Margin
31.19% 32.10% 33.32% 33.01% 34.62% 36.30% 36.83% 36.31% 36.43% 39.79% 41.78%
Operating Margin
27.87% 29.10% 30.33% 30.48% 33.09% 33.67% 34.35% 33.87% 35.04% 37.39% 39.95%
EBIT Margin
28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44% 38.01% 40.30%
Profit (Net Income) Margin
25.46% 26.35% 26.79% 27.22% 28.19% 33.26% 29.46% 29.82% 31.25% 33.88% 33.50%
Tax Burden Percent
88.35% 88.39% 86.26% 88.34% 86.59% 96.69% 84.37% 86.79% 90.75% 89.13% 83.12%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
11.65% 11.61% 13.74% 11.66% 13.41% 3.31% 15.63% 13.21% 9.25% 10.87% 16.88%
Return on Invested Capital (ROIC)
46.36% 49.28% 53.45% 55.63% 61.84% 76.79% 73.89% 72.93% 76.13% 83.33% 95.40%
ROIC Less NNEP Spread (ROIC-NNEP)
41.47% 45.15% 49.32% 53.74% 64.46% 74.15% 72.35% 71.00% 79.38% 81.35% 94.60%
Return on Net Nonoperating Assets (RNNOA)
-3.29% -3.21% -3.75% -4.22% -6.09% -11.17% -12.76% -8.92% -7.83% -13.66% -23.20%
Return on Equity (ROE)
43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30% 69.67% 72.20%
Cash Return on Invested Capital (CROIC)
52.90% 50.81% 58.12% 46.41% 42.90% 64.31% 67.19% 70.33% 62.19% 48.86% 67.88%
Operating Return on Assets (OROA)
21.87% 23.69% 25.43% 25.86% 29.17% 31.64% 33.02% 34.27% 36.64% 39.36% 43.64%
Return on Assets (ROA)
19.33% 20.94% 21.94% 22.84% 25.26% 30.59% 27.86% 29.74% 33.25% 35.08% 36.27%
Return on Common Equity (ROCE)
43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30% 69.67% 72.20%
Return on Equity Simple (ROE_SIMPLE)
45.00% 0.00% 47.89% 48.75% 48.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
934 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858 2,240 2,729
NOPAT Margin
24.62% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80% 33.32% 33.21%
Net Nonoperating Expense Percent (NNEP)
4.89% 4.13% 4.13% 1.88% -2.62% 2.64% 1.54% 1.93% -3.25% 1.98% 0.80%
Return On Investment Capital (ROIC_SIMPLE)
- - - 8.55% 9.66% 11.73% 10.52% 10.74% 12.97% 13.82% 15.47%
Cost of Revenue to Revenue
52.54% 52.47% 51.95% 52.63% 50.98% 49.92% 49.57% 50.40% 50.17% 48.25% 47.70%
SG&A Expenses to Revenue
5.69% 5.59% 5.83% 5.58% 4.79% 5.19% 5.25% 5.01% 4.80% 4.80% 4.24%
R&D to Revenue
13.50% 12.86% 11.88% 11.31% 11.14% 11.22% 10.83% 10.73% 9.98% 9.56% 8.11%
Operating Expenses to Revenue
19.60% 18.43% 17.72% 16.89% 15.93% 16.41% 16.07% 15.73% 14.78% 14.36% 12.35%
Earnings before Interest and Taxes (EBIT)
1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012 2,555 3,312
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,183 1,243 1,389 1,444 1,634 1,877 1,961 1,941 2,128 2,675 3,434
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
15.85 16.30 12.68 10.72 9.80 12.61 15.93 22.05 24.94 38.01 28.36
Price to Tangible Book Value (P/TBV)
20.33 20.55 16.00 13.40 12.08 15.44 19.41 27.01 30.34 44.83 32.88
Price to Revenue (P/Rev)
8.93 9.34 6.89 5.83 5.44 6.74 8.29 10.88 12.18 20.41 15.10
Price to Earnings (P/E)
35.22 36.37 26.48 22.00 20.01 23.20 27.95 36.00 39.36 65.25 46.68
Dividend Yield
0.80% 0.75% 1.00% 1.17% 1.23% 0.95% 0.74% 0.68% 0.48% 0.27% 0.35%
Earnings Yield
2.84% 2.75% 3.78% 4.55% 5.00% 4.31% 3.58% 2.78% 2.54% 1.53% 2.14%
Enterprise Value to Invested Capital (EV/IC)
17.24 18.03 14.39 11.54 10.80 15.39 20.07 26.27 27.49 44.44 38.28
Enterprise Value to Revenue (EV/Rev)
8.88 9.28 6.82 5.78 5.38 6.64 8.18 10.80 12.13 20.33 14.95
Enterprise Value to EBITDA (EV/EBITDA)
28.54 29.31 21.30 17.83 16.16 19.30 23.16 29.94 33.26 54.25 38.39
Enterprise Value to EBIT (EV/EBIT)
31.07 31.73 22.97 19.17 17.29 20.55 24.56 31.66 35.13 57.15 40.22
Enterprise Value to NOPAT (EV/NOPAT)
35.71 36.96 26.93 22.33 19.98 23.07 27.82 36.08 39.51 65.49 46.53
Enterprise Value to Operating Cash Flow (EV/OCF)
25.74 29.74 20.18 20.57 20.58 19.83 25.10 31.17 37.81 80.62 51.57
Enterprise Value to Free Cash Flow (EV/FCFF)
31.61 35.00 23.98 25.74 27.08 24.36 31.02 38.08 46.70 104.03 63.29
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.62 0.58 0.59 0.57 0.47 0.45 0.44 0.44 0.35 0.30 0.27
Long-Term Debt to Equity
0.56 0.52 0.53 0.51 0.39 0.38 0.37 0.37 0.35 0.30 0.27
Financial Leverage
-0.08 -0.07 -0.08 -0.08 -0.09 -0.15 -0.18 -0.13 -0.10 -0.17 -0.25
Leverage Ratio
2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03 2.01 2.00
Compound Leverage Factor
2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03 2.01 2.00
Debt to Total Capital
38.32% 36.85% 37.04% 36.13% 32.04% 31.26% 30.55% 30.65% 26.08% 23.05% 21.17%
Short-Term Debt to Total Capital
3.88% 3.73% 3.75% 3.66% 5.39% 5.26% 5.14% 5.15% 0.03% 0.03% 0.02%
Long-Term Debt to Total Capital
34.43% 33.12% 33.29% 32.47% 26.65% 26.00% 25.41% 25.50% 26.05% 23.02% 21.15%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
61.68% 63.15% 62.96% 63.87% 67.96% 68.74% 69.45% 69.35% 73.92% 76.95% 78.83%
Debt to EBITDA
1.12 1.06 1.00 0.95 0.79 0.71 0.65 0.60 0.47 0.43 0.37
Net Debt to EBITDA
-0.16 -0.18 -0.22 -0.13 -0.17 -0.30 -0.32 -0.23 -0.13 -0.21 -0.36
Long-Term Debt to EBITDA
1.01 0.95 0.90 0.85 0.65 0.59 0.54 0.50 0.47 0.43 0.37
Debt to NOPAT
1.41 1.33 1.26 1.19 0.97 0.85 0.78 0.73 0.56 0.52 0.44
Net Debt to NOPAT
-0.19 -0.23 -0.27 -0.16 -0.21 -0.36 -0.38 -0.28 -0.15 -0.26 -0.44
Long-Term Debt to NOPAT
1.26 1.20 1.13 1.07 0.81 0.70 0.65 0.61 0.56 0.52 0.44
Altman Z-Score
10.78 11.58 9.18 8.55 8.87 9.98 11.87 15.68 19.57 29.64 22.90
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.82 2.97 2.53 2.54 2.45 2.21 2.21 2.26 2.54 2.63 2.48
Quick Ratio
1.78 1.93 1.69 1.68 1.58 1.49 1.54 1.56 1.69 1.84 1.79
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,393 1,205 1,577 622 141 1,403 948 1,247 834 -431 507
Operating Cash Flow to CapEx
1,336.02% 856.03% 1,418.30% 393.92% 454.31% 1,483.35% 960.97% 567.33% 344.21% 771.83% 1,357.27%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.76 0.79 0.82 0.84 0.90 0.92 0.95 1.00 1.06 1.04 1.08
Accounts Receivable Turnover
5.21 5.58 5.42 5.39 6.31 6.25 5.96 6.05 5.89 5.33 5.62
Inventory Turnover
1.64 1.74 1.83 1.93 2.03 2.22 2.39 2.46 2.56 2.68 2.96
Fixed Asset Turnover
0.00 7.43 7.21 7.27 7.53 8.04 8.29 8.18 8.30 8.63 9.27
Accounts Payable Turnover
13.36 14.48 13.29 12.85 12.86 12.88 12.67 11.16 11.27 10.67 10.42
Days Sales Outstanding (DSO)
70.04 65.41 67.28 67.69 57.85 58.38 61.20 60.33 61.96 68.48 64.90
Days Inventory Outstanding (DIO)
221.91 209.96 199.59 188.85 180.04 164.54 152.63 148.46 142.41 136.14 123.38
Days Payable Outstanding (DPO)
27.33 25.21 27.46 28.41 28.38 28.33 28.81 32.70 32.39 34.20 35.04
Cash Conversion Cycle (CCC)
264.62 250.17 239.42 228.13 209.51 194.59 185.02 176.09 171.98 170.42 153.24
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,333 7,675 7,388 8,125 8,545 7,955 7,984 8,449 9,568 10,626 10,207
Invested Capital Turnover
1.88 1.92 2.04 2.07 2.16 2.36 2.55 2.48 2.39 2.50 2.87
Increase / (Decrease) in Invested Capital
-459 -210 -487 557 1,211 281 595 324 1,024 2,671 2,223
Enterprise Value (EV)
126,449 138,355 106,339 93,760 92,240 122,424 160,208 221,965 262,986 472,234 390,727
Market Capitalization
127,138 139,220 107,423 94,443 93,207 124,330 162,417 223,661 264,003 474,079 394,429
Book Value per Share
$61.19 $65.32 $65.23 $6.85 $7.41 $7.71 $8.05 $8.08 $8.48 $9.97 $11.12
Tangible Book Value per Share
$47.70 $51.82 $51.69 $5.48 $6.01 $6.30 $6.61 $6.59 $6.97 $8.46 $9.59
Total Capital
13,006 13,523 13,456 13,790 13,995 14,346 14,677 14,629 14,319 16,205 17,644
Total Debt
4,983 4,983 4,984 4,982 4,484 4,485 4,484 4,484 3,734 3,735 3,735
Total Long-Term Debt
4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730 3,730 3,730 3,732
Net Debt
-689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016 -1,845 -3,702
Capital Expenditures (CapEx)
104 101 111 188 288 172 185 261 332 189 258
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,891 3,202 2,587 3,101 3,274 2,312 2,160 2,378 3,308 4,098 3,378
Debt-free Net Working Capital (DFNWC)
8,563 9,050 8,654 8,767 8,725 8,703 8,853 8,559 8,059 9,678 10,815
Net Working Capital (NWC)
8,058 8,545 8,150 8,263 7,970 7,949 8,099 7,805 8,055 9,673 10,812
Net Nonoperating Expense (NNE)
-32 -25 -26 -13 22 -37 -25 -23 32 -37 -24
Net Nonoperating Obligations (NNO)
-689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016 -1,845 -3,702
Total Depreciation and Amortization (D&A)
90 88 94 96 97 98 102 104 116 120 122
Debt-free, Cash-free Net Working Capital to Revenue
20.30% 21.48% 16.59% 19.13% 19.11% 12.54% 11.03% 11.57% 15.26% 17.64% 12.93%
Debt-free Net Working Capital to Revenue
60.13% 60.71% 55.51% 54.09% 50.92% 47.21% 45.19% 41.63% 37.17% 41.65% 41.39%
Net Working Capital to Revenue
56.59% 57.33% 52.27% 50.97% 46.51% 43.12% 41.34% 37.96% 37.15% 41.64% 41.38%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$7.38 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46 $1.81 $2.20
Adjusted Weighted Average Basic Shares Outstanding
130.84M 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B 1.26B 1.25B
Adjusted Diluted Earnings per Share
$7.34 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45 $1.81 $2.19
Adjusted Weighted Average Diluted Shares Outstanding
131.52M 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B 1.26B 1.26B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $1.34 $0.00 $0.00 $0.00 $1.81 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B 1.25B 1.25B
Normalized Net Operating Profit after Tax (NOPAT)
947 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858 2,240 2,729
Normalized NOPAT Margin
24.97% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80% 33.32% 33.21%
Pre Tax Income Margin
28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44% 38.01% 40.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
27.42% 26.62% 25.87% 25.22% 23.95% 21.45% 20.32% 19.48% 18.49% 17.49% 15.43%
Augmented Payout Ratio
119.89% 100.89% 99.74% 96.23% 77.70% 85.32% 78.85% 86.59% 91.49% 70.50% 61.59%

Financials Breakdown Chart

Key Financial Trends

Lam Research’s Q1 2027 results show a sharp acceleration in revenue, earnings and cash generation compared with the prior quarter. The supplied statements also show a strong recovery from the lower revenue levels seen during fiscal 2024, though some balance-sheet and cash-flow measures warrant monitoring.

  • Revenue and earnings climbed. Q1 2027 revenue rose 22% sequentially to $8.22 billion from $6.72 billion in Q4 2026. Net income increased about 21% to $2.75 billion, while diluted earnings per share advanced to $2.19 from $1.81.
  • Profitability improved alongside growth. Gross margin increased to about 52.3% from 51.7% in Q4 2026, and operating margin rose to roughly 40.0% from 37.4%. This suggests the latest revenue growth was accompanied by better operating leverage.
  • The longer-term revenue trend is substantially higher. Revenue grew from $3.48 billion in Q1 2024 to $8.22 billion in Q1 2027. The path included a decline and recovery, but the latest quarter is well above the earlier period’s levels.
  • Operating cash flow strengthened. Cash from operations was $3.50 billion in Q1 2027, up from $1.46 billion in Q4 2026. After $258 million of capital expenditures, estimated free cash flow was about $3.24 billion.
  • Liquidity and net cash remain robust. Cash and equivalents reached $7.44 billion at Q1 2027 quarter-end. Against approximately $3.74 billion of total debt, Lam Research had about $3.71 billion of net cash; current assets were roughly 2.5 times current liabilities.
  • Shareholder returns continued. The company used about $1.02 billion for share repurchases and paid $325 million in dividends during Q1 2027. These distributions were supported by strong operating cash generation.
  • Working-capital balances are rising. Accounts receivable increased to $5.66 billion and inventory to $4.55 billion. These balances can grow with sales, but investors may want to watch whether collections and inventory levels remain in line with demand.
  • Cash distributions are a sizable use of funds. Buybacks and dividends totaled about $1.35 billion in Q1 2027, contributing to a $1.38 billion financing cash outflow. These returns benefit shareholders but reduce cash available for other uses.
  • Income-tax expense rose notably. Tax expense was $559 million in Q1 2027, compared with $278 million in Q4 2026. The effective tax rate increased to about 16.9% from 10.9%, which partially limited the conversion of higher pretax income into net income.
11/11/26 01:45 PM ETAI Generated. May Contain Errors.

Lam Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lam Research's financial year ends in June. Their financial year 2026 ended on June 28, 2026.

Lam Research's net income appears to be on an upward trend, with a most recent value of $7.27 billion in 2026, rising from $914.05 million in 2016. The previous period was $5.36 billion in 2025. View Lam Research's forecast to see where analysts expect Lam Research to go next.

Lam Research's total operating income in 2026 was $8.20 billion, based on the following breakdown:
  • Total Gross Profit: $11.73 billion
  • Total Operating Expenses: $3.53 billion

Over the last 10 years, Lam Research's total revenue changed from $5.89 billion in 2016 to $23.23 billion in 2026, a change of 294.7%.

In the past 12 quarters, Lam Research's cash and equivalents has ranged from $4.75 billion in Q3 2026 to $7.44 billion in Q1 2027, and is currently $7.44 billion as of their latest financial filing in Q1 2027.

Lam Research had total debt of $3.73 billion at the end of 2026, a 16.7% decrease from 2025, and a 13.7% decrease since 2016.

Over the last 10 years, Lam Research's book value per share changed from 36.93 in 2016 to 9.97 in 2026, a change of -73.0%.



Financial statements for NASDAQ:LRCX last updated on 10/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners